Drug discontinuation after treatment with minimum maintenance dose of an antithyroid drug in Graves' disease: a retrospective study on effects of treatment duration with minimum maintenance dose on lasting remission.
http://www.ncbi.nlm.nih.gov/pubmed/21206137
Quote:
These findings suggest that in patients who discontinue ATD after a certain MMDT duration, the remission rate increases as the MMDT duration increases, and ATD should not be discontinued in TRAb-positive patients with MMDT durations of 6 months or less.
Thanks Pam, I am so thankfull that you post actual studies that I can pass on to my FNP, she's very research oriented. I saw her today, and she never once mentioned RAI or TT, just refilled my prescription of MMI for an entire year :) I love her!
Remission of Graves' hyperthyroidism predicted by smooth decreases of thyroid-stimulating antibody and thyrotropin-binding inhibitor immunoglobulin during antithyroid drug treatment.
http://www.ncbi.nlm.nih.gov/pubmed/9364248
Plus my thoughts in a discussion here:
http://www.dailystrength.org/c/Graves_Disease/forum/15428778-do-you-think/page-2
http://www.ncbi.nlm.nih.gov/pubmed/11081255